
Sofosbuvir (400mg) + Velpatasvir (100mg)
Active composition
+1 more active ingredient
Sofosbuvir inhibits the HCV NS5B polymerase, preventing viral replication.
Medical applications
Myhep All Tablet is a pharmaceutical formulation comprising Sofosbuvir 400mg and Velpatasvir 100mg, a fixed-dose combination antiviral medication. This product is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults, including those with compensated cirrhosis. The dual antiviral action of Sofosbuvir and Velpatasvir helps inhibit HCV replication, potentially leading to sustained virologic responses and improvement in liver function. The recommended dosage is one tablet once daily with or without food. Consult a healthcare professional for dosing instructions and to monitor for potential adverse effects, drug interactions, and treatment efficacy. Myhep All Tablet should be used as part of a comprehensive treatment plan for HCV, including lifestyle modifications and regular follow-ups.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Myhep All Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Myhep All Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Myhep All Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Myhep All Tablet may be needed. Please consult your doctor. Limited information is available on the use of Myhep All Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Exercise Caution
Myhep All Tablet may cause side effects which could affect your ability to drive. Myhep All Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive.
Consult Doctor
Myhep All Tablet is safe to use in patients with liver disease. No dose adjustment of Myhep All Tablet is recommended. However, inform your doctor if you have any kidney disease as regular monitoring of liver function tests may be advised in some patients while taking this medicine.
Regular Checkup
0 reviews for Myhep All Tablet

Sofosbuvir (400mg) + Velpatasvir (100mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Sofosbuvir inhibits the HCV NS5B polymerase, preventing viral replication.
Medical applications
Myhep All Tablet is a pharmaceutical formulation comprising Sofosbuvir 400mg and Velpatasvir 100mg, a fixed-dose combination antiviral medication. This product is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults, including those with compensated cirrhosis. The dual antiviral action of Sofosbuvir and Velpatasvir helps inhibit HCV replication, potentially leading to sustained virologic responses and improvement in liver function. The recommended dosage is one tablet once daily with or without food. Consult a healthcare professional for dosing instructions and to monitor for potential adverse effects, drug interactions, and treatment efficacy. Myhep All Tablet should be used as part of a comprehensive treatment plan for HCV, including lifestyle modifications and regular follow-ups.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Myhep All Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Myhep All Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Myhep All Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Myhep All Tablet may be needed. Please consult your doctor. Limited information is available on the use of Myhep All Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Exercise Caution
Myhep All Tablet may cause side effects which could affect your ability to drive. Myhep All Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive.
Consult Doctor
Myhep All Tablet is safe to use in patients with liver disease. No dose adjustment of Myhep All Tablet is recommended. However, inform your doctor if you have any kidney disease as regular monitoring of liver function tests may be advised in some patients while taking this medicine.
Regular Checkup
0 reviews for Myhep All Tablet















